Metformin
Is It Right for You?
A complete guide to Metformin — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Metformin?
Metformin is a biguanide antidiabetic medication and the most widely prescribed drug for the management of type 2 diabetes mellitus worldwide. It is the first-line pharmacological treatment for type 2 diabetes in most international guidelines, including those of the National Institute for Health and Care Excellence (NICE) in the UK, and has been used clinically for over 60 years.
Metformin is uniquely valued among antidiabetic agents for its excellent safety profile, absence of hypoglycaemia risk when used as monotherapy, weight-neutral or modest weight-reducing effect, and cardiovascular benefits demonstrated in landmark clinical trials. It lowers blood glucose primarily by reducing hepatic glucose production, without stimulating insulin secretion.
Beyond its primary indication, metformin is also used in the management of polycystic ovary syndrome (PCOS) — both for metabolic control and to improve fertility outcomes — and in the prevention of type 2 diabetes in individuals at high risk. It is available as standard tablets, modified-release (MR) tablets, and oral solution, and is suitable for adults and children over 10 years with type 2 diabetes.
Metformin is a prescription-only medication in the UK. A licensed clinician must assess your blood glucose levels, medical history, and kidney function before it can be prescribed — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Metformin Used For?
Metformin is prescribed for:
first-line treatment, used alone or in combination with other antidiabetic agents (including insulin) to improve glycaemic control.
in individuals with pre-diabetes (impaired fasting glucose or impaired glucose tolerance) and multiple risk factors, particularly where lifestyle intervention alone has been insufficient.
to improve insulin sensitivity, regulate menstrual cycles, reduce androgen levels, and improve fertility outcomes in women with PCOS who are overweight or insulin-resistant.
used under specialist supervision as an alternative or adjunct to insulin in selected patients.
Metformin significantly lowers blood glucose and reduces the long-term complications of type 2 diabetes, but does not cure the condition. It works most effectively alongside dietary modification, weight management, and regular physical activity. Lifestyle measures remain the cornerstone of diabetes management.
How Does Metformin Work?
Metformin's primary mechanism of action is the suppression of hepatic gluconeogenesis — the liver's production of glucose from non-carbohydrate sources. In type 2 diabetes, the liver produces excessive amounts of glucose even in the fed state, contributing significantly to elevated fasting blood glucose. Metformin inhibits mitochondrial Complex I in hepatocytes, reducing hepatic energy availability and activating AMP-activated protein kinase (AMPK), a key cellular energy sensor that suppresses gluconeogenic gene expression.
In addition to reducing hepatic glucose output, metformin increases insulin sensitivity in peripheral tissues, reduces intestinal glucose absorption to a modest degree, slows the rate of gastrointestinal glucose uptake, and has beneficial effects on the gut microbiome that may contribute to its metabolic effects. Crucially, metformin does not stimulate insulin secretion, which means it does not cause hypoglycaemia when used as monotherapy and does not promote weight gain — a significant advantage over sulfonylureas and insulin.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Always take metformin with or immediately after meals. This significantly reduces gastrointestinal side effects (nausea, diarrhoea, abdominal discomfort) which are the most common reason patients stop taking it. Food slows absorption and reduces peak plasma concentrations.
Modified-release (MR) tablets are associated with fewer gastrointestinal side effects than standard-release formulations and may be a better option for patients who struggle with GI symptoms. Take MR tablets whole with the evening meal — do not crush or chew.
Titrate the dose slowly — starting at a low dose (500 mg) and increasing gradually over several weeks allows the gut to adjust and dramatically reduces GI intolerance.
Do not take metformin if you are acutely unwell, particularly if dehydrated, vomiting, or have a significant infection — these states reduce kidney function and increase the risk of lactic acidosis. Many clinicians advise "sick day rules" — temporarily withholding metformin during acute illness. Discuss this with your clinician.
Hold metformin before contrast-enhanced CT scans — iodinated contrast media can acutely impair renal function, raising the risk of metformin accumulation. Follow your radiology department's guidance, which typically involves withholding metformin for 48 hours before and after the procedure.
Side Effects of Metformin
Metformin's gastrointestinal side effects are very common at initiation but typically improve significantly over the first 2 to 4 weeks of treatment and can be substantially reduced by dose titration and administration with food. Serious side effects are rare.
- Nausea and vomiting (particularly at initiation)
- Diarrhoea and loose stools
- Abdominal pain and bloating
- Loss of appetite
- Metallic taste
- Lactic acidosis — a rare but potentially fatal complication in which excess lactic acid accumulates in the blood; symptoms include muscle pain or weakness, difficulty breathing, nausea and vomiting, feeling cold, dizziness, and slow or irregular heartbeat; risk is highest in patients with renal impairment, hepatic disease, heart failure, or who are acutely unwell and dehydrated.
- Vitamin B12 deficiency — long-term metformin use reduces B12 absorption from the gut; can cause peripheral neuropathy and anaemia; periodic monitoring of B12 levels is recommended.
Lactic acidosis associated with metformin, while rare, carries a high mortality rate. It almost exclusively occurs in patients with significant contraindications to metformin — particularly severe renal impairment (eGFR below 30 mL/min/1.73m²), hepatic failure, or severe dehydration and acute illness. Metformin must be avoided or dose-adjusted based on eGFR. Never take metformin if you have been told to stop it during illness, before surgery, or before contrast imaging.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting metformin.
Acute renal impairment following contrast administration can cause metformin accumulation and precipitate lactic acidosis. Metformin should be withheld before and for 48 hours after contrast procedures.
Can raise blood glucose and impair renal function, both of which affect metformin efficacy and safety.
May affect renal function; monitor eGFR if initiating or changing these agents in a patient on metformin.
Reduces renal excretion of metformin, raising its plasma levels; monitor for increased side effects.
Important Warnings
Metformin is contraindicated in patients with eGFR below 30 mL/min/1.73m², severe hepatic impairment, decompensated heart failure, or respiratory failure. It should be used with caution and at reduced doses in patients with eGFR 30–45. Seek emergency medical attention if you experience unexplained muscle pain, difficulty breathing, stomach pain, nausea, or dizziness while taking metformin — these may be symptoms of lactic acidosis.
Renal function (eGFR) must be checked before starting metformin and monitored at least annually during treatment — more frequently in patients with pre-existing renal impairment or conditions that may affect kidney function. The dose must be adjusted or metformin discontinued if eGFR falls.
Metformin should be temporarily discontinued during episodes of acute illness associated with dehydration, vomiting, diarrhoea, or reduced fluid intake, as these states reduce kidney function and raise the risk of lactic acidosis. Resume metformin only once you are recovered and eating and drinking normally. Discuss your clinician's specific sick day guidance.
Long-term use of metformin reduces absorption of Vitamin B12 by interfering with the calcium-dependent binding of the intrinsic factor-B12 complex in the terminal ileum. Patients on long-term metformin should have B12 levels checked periodically (every 2 to 3 years) and supplement if deficient.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Metformin FAQs
No — not when used as monotherapy. Metformin works by reducing hepatic glucose production and improving insulin sensitivity; it does not stimulate insulin release. This means it cannot cause hypoglycaemia on its own. However, if metformin is combined with insulin or a sulfonylurea (such as gliclazide), hypoglycaemia can occur from those agents
Gastrointestinal side effects — nausea, diarrhoea, and bloating — are very common at initiation and are the most frequent reason patients stop taking metformin. They can be dramatically reduced by always taking metformin with food, starting at the lowest dose and increasing gradually over several weeks, and switching to the modified-release formulation if standard-release causes persistent GI problems. For the majority of patients, GI symptoms settle within 2 to 4 weeks.
Metformin is weight-neutral to mildly weight-reducing compared to other antidiabetic agents that promote weight gain. It does not cause significant weight loss on its own, but it does not contribute to weight gain, and the reduced appetite associated with GI side effects at initiation may result in modest early weight reduction. It is often chosen in overweight patients with type 2 diabetes for this reason.
Standard-release metformin is taken two to three times daily with meals and is associated with more frequent gastrointestinal side effects due to its faster absorption and higher peak plasma concentrations. Modified-release (MR) metformin is taken once daily with the evening meal, releases the drug more slowly, and is associated with fewer and milder GI side effects — making it a preferable option for patients who struggle with standard tablets.
Your clinician will advise on blood glucose and HbA1c monitoring based on your individual diabetes management plan. As metformin does not cause hypoglycaemia as monotherapy, intensive home glucose monitoring is not always required compared to patients on insulin or sulfonylureas. HbA1c (a measure of average blood glucose over 3 months) is typically checked every 3 to 6 months until stable, then annually.